The store will not work correctly when cookies are disabled.
3-(4-(tert-Butyl)benzamido)-5-chloropicolinic acid
ID: ALA4743039
PubChem CID: 162643753
Max Phase: Preclinical
Molecular Formula: C17H17ClN2O3
Molecular Weight: 332.79
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1ccc(C(=O)Nc2cc(Cl)cnc2C(=O)O)cc1
Standard InChI: InChI=1S/C17H17ClN2O3/c1-17(2,3)11-6-4-10(5-7-11)15(21)20-13-8-12(18)9-19-14(13)16(22)23/h4-9H,1-3H3,(H,20,21)(H,22,23)
Standard InChI Key: SOGATWAJQFUBEN-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
14.0394 -2.5919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0383 -3.4114 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7463 -3.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4560 -3.4109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4531 -2.5883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7445 -2.1830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7421 -1.3658 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.7461 -4.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0383 -5.0460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4537 -5.0463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1643 -3.8184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8714 -3.4087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5797 -3.8162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8701 -2.5915 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5764 -4.6318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2839 -5.0392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9920 -4.6295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9880 -3.8081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2800 -3.4044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7008 -5.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7032 -5.8532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4074 -4.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4050 -5.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
3 8 1 0
8 9 1 0
8 10 2 0
4 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 13 1 0
17 20 1 0
20 21 1 0
20 22 1 0
20 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.79 | Molecular Weight (Monoisotopic): 332.0928 | AlogP: 3.98 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.29 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 0.92 | CX Basic pKa: 4.99 | CX LogP: 3.46 | CX LogD: 1.41 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.89 | Np Likeness Score: -1.50 |
References
1. Khalifa MM,Martorelli Di Genova B,McAlpine SG,Gallego-Lopez GM,Stevenson DM,Rozema SD,Monaghan NP,Morris JC,Knoll LJ,Golden JE. (2020) Dual-Stage Picolinic Acid-Derived Inhibitors of Toxoplasma gondii., 11 (12): [PMID:33335660] [10.1021/acsmedchemlett.0c00267] |